1. Clinical, biomarker and endoscopic outcomes in patients with Crohn's disease treated with Ustekinumab: Multi‐centre real world study. Issue 3 (3rd May 2021) Authors: Kamperidis, Nikolaos; Fenech, Valerie; Thoua, Nora; Cole, Alexander; Segal, Jonathan P.; Peake, Simon; Arebi, Naila Journal: GastroHep Issue: Volume 3:Issue 3(2021) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023) Authors: Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 2(2023) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-064 Combined inflammatory bowel disease– obstetric clinic, a district general hospital experience over 2 years. (8th June 2018) Authors: Thoua, Nora; Hall, Alexandra; Papadia, Cinzia; Dorman, Edgar; Parisaei, Maryam Journal: Gut Issue: Volume 67(2018)Supplement 1 Page Start: A99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗